Matches in Wikidata for { <http://www.wikidata.org/entity/Q91433301> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91433301 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91433301 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91433301 description "scientific article published on 07 February 2019" @default.
- Q91433301 description "wetenschappelijk artikel" @default.
- Q91433301 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91433301 name "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 name "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 type Item @default.
- Q91433301 label "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 label "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 prefLabel "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 prefLabel "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pem" @default.
- Q91433301 P1433 Q91433301-A0942AE2-5F32-452B-8018-7F8DB712E959 @default.
- Q91433301 P1476 Q91433301-65A63178-44F6-421B-A278-FC377A9F8E72 @default.
- Q91433301 P2093 Q91433301-63F35614-B814-4446-9CD0-0084975DBCE2 @default.
- Q91433301 P2093 Q91433301-CDBC018A-AEE2-4FA2-88BE-559B876726DF @default.
- Q91433301 P2093 Q91433301-F48382A2-5EB6-4D04-8CA0-1F6BDBD7EF12 @default.
- Q91433301 P304 Q91433301-DB0E36A7-9E48-48EA-ACE5-5327606C5B15 @default.
- Q91433301 P31 Q91433301-6D851A66-899F-470C-B57F-DC21D5750C1B @default.
- Q91433301 P356 Q91433301-DD2E01A4-BB74-4644-9D02-D025814A685D @default.
- Q91433301 P433 Q91433301-508FC535-245D-4864-96A4-F3C39A03178D @default.
- Q91433301 P478 Q91433301-0856C4EE-89B3-49D9-A257-701940CD8620 @default.
- Q91433301 P577 Q91433301-4DCA120E-FE63-4AB8-B9D1-EFEC33D26F2C @default.
- Q91433301 P698 Q91433301-FBAA03FD-BBDF-4256-90C3-AEFFBE662435 @default.
- Q91433301 P921 Q91433301-79EDA779-FC1A-4C74-BF42-84919FE0401E @default.
- Q91433301 P356 J.JAAD.2019.01.086 @default.
- Q91433301 P698 30738123 @default.
- Q91433301 P1433 Q15757046 @default.
- Q91433301 P1476 "Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid" @default.
- Q91433301 P2093 "Adam D Lipworth" @default.
- Q91433301 P2093 "Anar Mikailov" @default.
- Q91433301 P2093 "Zachary Schwager" @default.
- Q91433301 P304 "e189-e190" @default.
- Q91433301 P31 Q13442814 @default.
- Q91433301 P356 "10.1016/J.JAAD.2019.01.086" @default.
- Q91433301 P433 "6" @default.
- Q91433301 P478 "80" @default.
- Q91433301 P577 "2019-02-07T00:00:00Z" @default.
- Q91433301 P698 "30738123" @default.
- Q91433301 P921 Q1004647 @default.